Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
CLPT ClearPoint Neuro
- 12.000
- -0.240-1.96%
Close Dec 3 16:00 ET
- 12.000
- 0.0000.00%
Post 20:01 ET
331.02MMarket Cap-17391P/E (TTM)
12.150High11.830Low119.37KVolume12.150Open12.240Pre Close1.42MTurnover0.47%Turnover RatioLossP/E (Static)27.58MShares14.12552wk High11.42P/B305.09MFloat Cap5.10552wk Low--Dividend TTM25.42MShs Float31.290Historical High--Div YieldTTM2.61%Amplitude2.860Historical Low11.935Avg Price1Lot Size
ClearPoint Neuro Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 40.96%8.12M | 32.07%7.86M | 40.60%7.64M | 16.56%23.96M | 31.62%6.81M | 11.97%5.76M | 14.42%5.95M | 7.99%5.43M | 26.09%20.55M | 20.83%5.17M |
| Operating revenue | 40.96%8.12M | 32.07%7.86M | 40.60%7.64M | 16.56%23.96M | 31.62%6.81M | 11.97%5.76M | 14.42%5.95M | 7.99%5.43M | 26.09%20.55M | 20.83%5.17M |
| Cost of revenue | 31.58%3.28M | 1.63%2.87M | 39.58%3.11M | 47.31%10.34M | 54.70%2.8M | 69.67%2.49M | 45.19%2.82M | 23.94%2.23M | 35.63%7.02M | 64.66%1.81M |
| Gross profit | 48.09%4.85M | 59.56%4.99M | 41.32%4.53M | 0.61%13.61M | 19.22%4.01M | -11.04%3.27M | -3.96%3.13M | -0.90%3.2M | 21.65%13.53M | 5.72%3.37M |
| Operating expense | 22.63%10.02M | -5.17%9.73M | -1.77%8.76M | 20.75%36.06M | 11.28%8.72M | 9.31%8.17M | 37.51%10.26M | 25.64%8.91M | 21.90%29.86M | 9.34%7.84M |
| Selling and administrative expenses | 16.77%6.7M | -0.68%6.61M | 4.07%6.13M | 28.37%24.35M | 23.61%6.07M | 19.11%5.74M | 31.77%6.65M | 40.46%5.89M | 24.66%18.97M | 19.91%4.91M |
| -Selling and marketing expense | 24.92%3.55M | 10.36%3.83M | 12.17%3.29M | 34.59%12.6M | 32.19%3.35M | 17.30%2.84M | 45.54%3.47M | 45.34%2.93M | 29.67%9.36M | 17.44%2.53M |
| -General and administrative expense | 8.79%3.16M | -12.74%2.77M | -3.96%2.84M | 22.32%11.76M | 14.48%2.72M | 20.93%2.9M | 19.43%3.18M | 35.94%2.96M | 20.15%9.61M | 22.66%2.38M |
| Research and development costs | 36.48%3.32M | -13.45%3.12M | -13.17%2.63M | 7.48%11.71M | -9.40%2.65M | -8.48%2.43M | 49.52%3.61M | 4.21%3.02M | 17.38%10.89M | -4.75%2.93M |
| Operating profit | -5.62%-5.17M | 33.54%-4.74M | 25.93%-4.23M | -37.44%-22.45M | -5.30%-4.71M | -29.04%-4.9M | -69.62%-7.13M | -47.83%-5.71M | -22.12%-16.33M | -12.23%-4.47M |
| Net non-operating interest income expense | 109.00%209K | 302.47%326K | -2.63%111K | 576.54%386K | 8.33%91K | 212.50%100K | 189.01%81K | 207.55%114K | 91.68%-81K | 151.22%84K |
| Non-operating interest income | 109.00%209K | 302.47%326K | -2.63%111K | --386K | --91K | --100K | --81K | --114K | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.68%81K | ---- |
| Other net income (expense) | 8.33%-11K | 350.00%5K | -136.36%-26K | -31.82%-29K | -4K | 52.00%-12K | 75.00%-2K | -200.00%-11K | 65.08%-22K | 0 |
| Other non- operating income (expenses) | 8.33%-11K | 350.00%5K | -136.36%-26K | -31.82%-29K | ---4K | 52.00%-12K | 75.00%-2K | -200.00%-11K | 65.08%-22K | --0 |
| Income before tax | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Income tax | ||||||||||
| Net income | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Net income continuous Operations | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Basic earnings per share | 10.00%-0.18 | 44.83%-0.16 | 30.43%-0.16 | -32.35%-0.9 | -5.56%-0.19 | -33.33%-0.2 | -61.11%-0.29 | -35.29%-0.23 | 1.45%-0.68 | 5.26%-0.18 |
| Diluted earnings per share | 10.00%-0.18 | 44.83%-0.16 | 30.43%-0.16 | -32.35%-0.9 | -5.56%-0.19 | -33.33%-0.2 | -61.11%-0.29 | -35.29%-0.23 | 1.45%-0.68 | 5.26%-0.18 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
